The FDA has granted approval to Abrilada, making it the second interchangeable biosimilar to adalimumab. This decision allows Abrilada (adalimumab-afzb,…
Browsing: Hot headlines in GI
Robert Schoen, MD, and Dhiraj Yadav, MD — professors at the University of Pittsburgh School of Medicine — received 2024…
JERUSALEM (Reuters) – Teva Pharmaceutical Industries will collaborate with French drugmaker Sanofi to develop a treatment for inflammatory bowel disease…
The American Gastroenterological Association (AGA) has emphasized the critical need for best practice updates to enhance awareness and treatment of…
GRAIL, LLC, a healthcare company focused on early cancer detection, has unveiled detailed results from its PATHFINDER study on its…
A recent systematic review and meta-analysis presented at the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) 2023…
An exciting era of safer, more effective, and minimally invasive gastrointestinal patient care is being made possible with advances in…
Dr. Eric Esrailian, a gastroenterologist and health sciences clinical professor of medicine at UCLA, shared his perspective on the choice…
Gastroenterology Associates of New Jersey (GANJ) and Oshi Health have announced a groundbreaking partnership to introduce innovative hybrid models for…
An exciting era of safer, more effective, and minimally invasive gastrointestinal patient care is being made possible with advances in…